Suppr超能文献

诱导对日本柳杉花粉的口服耐受性。

Induction of oral tolerance to Japanese cedar pollen.

作者信息

Kim J H, Mun Y J, Ahn S H, Park J S, Woo W H

机构信息

Department of Herbal Resources, Professional Graduate School of Oriental Medicine, Wonkwang University, Iksan, Chunbuk, Korea.

出版信息

Arch Pharm Res. 2001 Dec;24(6):557-63. doi: 10.1007/BF02975165.

Abstract

Oral tolerance is thought to play a role in preventing allergic responses and immune-mediated diseases. An improved mouse model of the oral tolerance to Japanese cedar pollen (JCP) as antigen was developed in order to detect induction of the tolerance, and the immunological characteristics of this model were also elucidated. Oral tolerance was induced by C3H/ HeN mice given an oral administration of 10 mg JCP 7 days before immunization with an i.p. injection of 0.1 mg JCP in complete Freunds adjuvant (CFA). The effects of oral JCP on systemic immunity were assessed by enzyme-linked immunosorbent assay (ELISA) of immunoglobulin (Ig) levels in serum collected on day 7 or 14 after immunization. Oral tolerance to JCP was adequately induced on day 7 after immunization and was more effective in C3H/HeN mice than in BALB/c mice. The tolerance was primarily concerned with the decreased serum levels of antigen-specific IgG. In these mice, oral administration of JCP also suppressed various immune responses to the antigen including delayed-type hypersensitivity (DTH), total IgE level and anti-JCP IgG1 level. The suppression of these immune responses by the oral antigen was associated with a significant reduction in interleukin-4 (IL-4) production. These findings therefore indicate that this C3H/HeN mice model has potential use in detecting the induction of oral tolerance by JCP, and suggest that this tolerance model may be effective in the treatment and prevention of allergic responses caused by the antigen.

摘要

口服耐受被认为在预防过敏反应和免疫介导疾病中发挥作用。为了检测口服耐受的诱导情况,构建了一种以日本柳杉花粉(JCP)为抗原的改良口服耐受小鼠模型,并阐明了该模型的免疫学特征。口服耐受通过在腹腔注射0.1 mg JCP于完全弗氏佐剂(CFA)中免疫前7天给C3H/HeN小鼠口服10 mg JCP来诱导。通过酶联免疫吸附测定(ELISA)检测免疫后第7天或第14天收集的血清中免疫球蛋白(Ig)水平,评估口服JCP对全身免疫的影响。免疫后第7天充分诱导了对JCP的口服耐受,且在C3H/HeN小鼠中比在BALB/c小鼠中更有效。这种耐受主要与抗原特异性IgG血清水平降低有关。在这些小鼠中,口服JCP还抑制了对抗原的各种免疫反应,包括迟发型超敏反应(DTH)、总IgE水平和抗JCP IgG1水平。口服抗原对这些免疫反应的抑制与白细胞介素-4(IL-4)产生的显著减少有关。因此,这些发现表明该C3H/HeN小鼠模型在检测JCP诱导的口服耐受方面具有潜在用途,并表明这种耐受模型可能对治疗和预防由该抗原引起的过敏反应有效。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验